Key Record Dates
ClinicalTrials.gov Identifier: | NCT05283135 |
---|---|
Brief Title: | High Dose Risankizumab for Psoriasis (KNOCKOUT) |
First Submitted : | February 3, 2022 |
First Submitted that Met QC Criteria : | March 8, 2022 |
First Posted : | March 16, 2022 |
Last Update Submitted that Met QC Criteria : | March 12, 2024 |
Last Update Posted : | March 15, 2024 |